JP Stock MarketDetailed Quotes

4565 Nxera Pharma

Watchlist
  • 1053
  • +31+3.03%
20min DelayMarket Closed Dec 27 15:30 JST
94.67BMarket Cap-12.08P/E (Static)

Nxera Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
178.34%9.26B
574.06%8.11B
388.97%4.61B
-18.00%12.77B
5.25%7.29B
-46.18%3.33B
-10.09%1.2B
-15.73%943M
-12.10%15.57B
-50.94%6.93B
Cost of revenue
77.20%2B
1,630.08%2.3B
1,194.57%1.19B
234.99%3.1B
840.86%1.75B
439.23%1.13B
-45.27%133M
-68.06%92M
-0.75%926M
-36.95%186M
Gross profit
230.12%7.27B
442.80%5.81B
301.88%3.42B
-34.00%9.66B
-17.80%5.54B
-63.16%2.2B
-2.28%1.07B
2.41%851M
-12.73%14.64B
-51.24%6.74B
Operating expense
7.19%6.46B
95.05%6.39B
130.76%6.5B
71.23%19.19B
162.95%7.08B
116.26%6.03B
21.57%3.27B
-7.31%2.82B
-13.82%11.21B
-53.82%2.69B
Selling and administrative expenses
7.38%3.7B
199.04%4.37B
229.13%3.65B
127.67%9.97B
227.51%3.95B
280.22%3.44B
60.48%1.46B
-18.09%1.11B
11.09%4.38B
14.73%1.21B
-General and administrative expense
7.38%3.7B
199.04%4.37B
229.13%3.65B
127.67%9.97B
227.51%3.95B
280.22%3.44B
60.48%1.46B
-18.09%1.11B
11.09%4.38B
14.73%1.21B
Research and development costs
1.88%3.03B
11.62%2.32B
61.62%3.16B
35.16%10.08B
67.23%3.06B
54.49%2.97B
9.93%2.08B
8.48%1.96B
25.68%7.45B
14.51%1.83B
Other operating expenses
3,550.00%73M
-96.67%1M
--2M
4,600.00%94M
6,000.00%61M
--2M
500.00%30M
----
-99.94%2M
-99.97%1M
Total other operating income
-13.27%340M
3.67%311M
27.09%319M
50.80%944M
--0
790.91%392M
156.41%300M
107.44%251M
7,725.00%626M
416.36%348M
Operating profit
121.13%808M
73.77%-578M
-56.62%-3.08B
-377.24%-9.53B
-137.87%-1.53B
-219.91%-3.82B
-37.92%-2.2B
10.97%-1.96B
-8.98%3.44B
-49.36%4.05B
Net non-operating interest income (expenses)
120.28%57M
-29.64%216M
177.23%280M
-1,140.86%-1.15B
-531.03%-1.28B
-330.33%-281M
420.34%307M
242.25%101M
97.42%-93M
93.94%-203M
Non-operating interest income
-30.96%252M
-17.50%415M
70.33%465M
102.26%1.34B
1,146.43%349M
25.86%365M
117.75%503M
131.36%273M
233.17%663M
110.04%28M
Non-operating interest expense
-69.81%195M
1.53%199M
7.56%185M
230.03%2.5B
605.63%1.63B
284.52%646M
13.95%196M
-8.99%172M
-80.09%756M
-92.48%231M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
0
-958.00%-429M
612.12%338M
Special income (charges)
0
-991.26%-1.84B
0
Less:Write off
----
----
----
--0
----
----
----
----
991.26%1.84B
--0
Other non-operating income (expenses)
Income before tax
121.07%865M
80.92%-362M
-50.08%-2.8B
-1,090.72%-10.68B
-167.25%-2.82B
-449.66%-4.11B
-6.27%-1.9B
25.39%-1.86B
148.96%1.08B
-8.70%4.19B
Income tax
-140.85%-335M
185.55%1.06B
205.21%485M
-601.01%-3.49B
-550.26%-2.61B
-4.76%820M
-290.85%-1.24B
-7.96%-461M
219.18%696M
-66.78%579M
Net income
124.37%1.2B
-116.11%-1.42B
-134.02%-3.28B
-1,982.98%-7.19B
-105.77%-208M
-1,673.48%-4.93B
55.18%-658M
32.27%-1.4B
-62.44%382M
26.92%3.61B
Net income continuous operations
124.37%1.2B
-116.11%-1.42B
-134.02%-3.28B
-1,982.98%-7.19B
-105.77%-208M
-1,673.48%-4.93B
55.18%-658M
32.27%-1.4B
-62.44%382M
26.92%3.61B
Noncontrolling interests
Net income attributable to the company
124.37%1.2B
-116.11%-1.42B
-134.02%-3.28B
-1,982.98%-7.19B
-105.77%-208M
-1,673.48%-4.93B
55.18%-658M
32.27%-1.4B
-62.44%382M
26.92%3.61B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
124.37%1.2B
-116.11%-1.42B
-134.02%-3.28B
-1,982.98%-7.19B
-105.77%-208M
-1,673.48%-4.93B
55.18%-658M
32.27%-1.4B
-62.44%382M
26.92%3.61B
Gross dividend payment
Basic earnings per share
122.49%13.45
-97.51%-15.86
-114.38%-36.68
-1,962.82%-87.18
-104.83%-2.13
-1,665.71%-59.81
55.29%-8.03
32.61%-17.11
-62.65%4.68
26.01%44.14
Diluted earnings per share
122.49%13.45
-97.51%-15.86
-114.38%-36.68
-1,982.94%-87.18
-104.83%-2.13
-1,682.28%-59.81
55.29%-8.03
32.61%-17.11
-62.66%4.63
26.33%44.09
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 178.34%9.26B574.06%8.11B388.97%4.61B-18.00%12.77B5.25%7.29B-46.18%3.33B-10.09%1.2B-15.73%943M-12.10%15.57B-50.94%6.93B
Cost of revenue 77.20%2B1,630.08%2.3B1,194.57%1.19B234.99%3.1B840.86%1.75B439.23%1.13B-45.27%133M-68.06%92M-0.75%926M-36.95%186M
Gross profit 230.12%7.27B442.80%5.81B301.88%3.42B-34.00%9.66B-17.80%5.54B-63.16%2.2B-2.28%1.07B2.41%851M-12.73%14.64B-51.24%6.74B
Operating expense 7.19%6.46B95.05%6.39B130.76%6.5B71.23%19.19B162.95%7.08B116.26%6.03B21.57%3.27B-7.31%2.82B-13.82%11.21B-53.82%2.69B
Selling and administrative expenses 7.38%3.7B199.04%4.37B229.13%3.65B127.67%9.97B227.51%3.95B280.22%3.44B60.48%1.46B-18.09%1.11B11.09%4.38B14.73%1.21B
-General and administrative expense 7.38%3.7B199.04%4.37B229.13%3.65B127.67%9.97B227.51%3.95B280.22%3.44B60.48%1.46B-18.09%1.11B11.09%4.38B14.73%1.21B
Research and development costs 1.88%3.03B11.62%2.32B61.62%3.16B35.16%10.08B67.23%3.06B54.49%2.97B9.93%2.08B8.48%1.96B25.68%7.45B14.51%1.83B
Other operating expenses 3,550.00%73M-96.67%1M--2M4,600.00%94M6,000.00%61M--2M500.00%30M-----99.94%2M-99.97%1M
Total other operating income -13.27%340M3.67%311M27.09%319M50.80%944M--0790.91%392M156.41%300M107.44%251M7,725.00%626M416.36%348M
Operating profit 121.13%808M73.77%-578M-56.62%-3.08B-377.24%-9.53B-137.87%-1.53B-219.91%-3.82B-37.92%-2.2B10.97%-1.96B-8.98%3.44B-49.36%4.05B
Net non-operating interest income (expenses) 120.28%57M-29.64%216M177.23%280M-1,140.86%-1.15B-531.03%-1.28B-330.33%-281M420.34%307M242.25%101M97.42%-93M93.94%-203M
Non-operating interest income -30.96%252M-17.50%415M70.33%465M102.26%1.34B1,146.43%349M25.86%365M117.75%503M131.36%273M233.17%663M110.04%28M
Non-operating interest expense -69.81%195M1.53%199M7.56%185M230.03%2.5B605.63%1.63B284.52%646M13.95%196M-8.99%172M-80.09%756M-92.48%231M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests 0-958.00%-429M612.12%338M
Special income (charges) 0-991.26%-1.84B0
Less:Write off --------------0----------------991.26%1.84B--0
Other non-operating income (expenses)
Income before tax 121.07%865M80.92%-362M-50.08%-2.8B-1,090.72%-10.68B-167.25%-2.82B-449.66%-4.11B-6.27%-1.9B25.39%-1.86B148.96%1.08B-8.70%4.19B
Income tax -140.85%-335M185.55%1.06B205.21%485M-601.01%-3.49B-550.26%-2.61B-4.76%820M-290.85%-1.24B-7.96%-461M219.18%696M-66.78%579M
Net income 124.37%1.2B-116.11%-1.42B-134.02%-3.28B-1,982.98%-7.19B-105.77%-208M-1,673.48%-4.93B55.18%-658M32.27%-1.4B-62.44%382M26.92%3.61B
Net income continuous operations 124.37%1.2B-116.11%-1.42B-134.02%-3.28B-1,982.98%-7.19B-105.77%-208M-1,673.48%-4.93B55.18%-658M32.27%-1.4B-62.44%382M26.92%3.61B
Noncontrolling interests
Net income attributable to the company 124.37%1.2B-116.11%-1.42B-134.02%-3.28B-1,982.98%-7.19B-105.77%-208M-1,673.48%-4.93B55.18%-658M32.27%-1.4B-62.44%382M26.92%3.61B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 124.37%1.2B-116.11%-1.42B-134.02%-3.28B-1,982.98%-7.19B-105.77%-208M-1,673.48%-4.93B55.18%-658M32.27%-1.4B-62.44%382M26.92%3.61B
Gross dividend payment
Basic earnings per share 122.49%13.45-97.51%-15.86-114.38%-36.68-1,962.82%-87.18-104.83%-2.13-1,665.71%-59.8155.29%-8.0332.61%-17.11-62.65%4.6826.01%44.14
Diluted earnings per share 122.49%13.45-97.51%-15.86-114.38%-36.68-1,982.94%-87.18-104.83%-2.13-1,682.28%-59.8155.29%-8.0332.61%-17.11-62.66%4.6326.33%44.09
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
Twenty-four seven
7074
290 +33.64%
Alpico Holdings
297A
321 +33.20%
Branding Technology
7067
1338 +28.90%
Estore
4304
1504 +24.92%
Axel Mark
3624
172 +22.86%

See the daily top gainer.